[Studies on the metabolic fate of 14C-rokitamycin. Absorption, distribution, metabolism and excretion in infant rats]

Jpn J Antibiot. 1988 Jul;41(7):797-808.
[Article in Japanese]

Abstract

14C-Rokitamycin (RKM) at the dose of 200 mg/kg was administered orally to fasted infant rats to study the absorption, distribution, metabolism and excretion in infant animals. The mean blood level of 14C-RKM reached its peak of 20.25 micrograms/ml in 30 minutes. The mean area under the curve was 93.23 micrograms.hr/ml. In vivo plasma protein binding rates of 14C-RKM were about 30% in both infant and adult rats. 14C-RKM was distributed at high concentrations into liver, kidney, lung, spleen, pancreas, bone marrow, submaxillary gland and some other tissues. Major metabolites detected in plasma, urine and bile were 10"-OH-RKM, leucomycin A7, leucomycin V and 14-OH-leucomycin V. In excretion studies, about 97% of the administered radioactivity was recovered in urine and feces within 144 hours. After intraduodenal administration to rats with cannulated bile ducts, 7.42% and 25.66% of the radioactivity were excreted within 24 hours in the urine and bile, respectively.

Publication types

  • English Abstract

MeSH terms

  • Absorption
  • Administration, Oral
  • Age Factors
  • Animals
  • Bile / metabolism
  • Leucomycins / administration & dosage
  • Leucomycins / metabolism
  • Leucomycins / pharmacokinetics*
  • Male
  • Miocamycin* / analogs & derivatives*
  • Rats
  • Rats, Inbred Strains
  • Tissue Distribution

Substances

  • Leucomycins
  • Miocamycin
  • rokitamycin